GSK256073
GSK256073 is a potent, orally bioavailable, and non-flushing full agonist of the hydroxy-carboxylic acid receptor 2 (HCA2/GPR109A) . It acutely improves glucose homeostasis by inhibiting lipolysis, making it a valuable research tool for studying metabolic disorders such as type 2 diabetes and dyslipidemia in both in vitro and in vivo models.
Product Specifications
CAS Number
862892-90-8
Product Name Alternative
Inhibit, Inhibitor, GPR109A, GPR109A (G-protein coupled receptor 109A), glucose, GSK 256073, GSK256073, GSK-256073, GPCR, HCAR2, HCA2, HCA2 (hydroxy-carboxylic acid receptor 2), HM74A, mellitus, homeostasis, dyslipidaemia, diabete, PUMA-G, type 2, T2DM
Field of Research
Metabolism Research, Pharmacology & Drug Discovery
Purity
98.03% (May vary between batches)
Solubility
10% DMSO+90% Corn Oil:1.5 mg/mL (5.84 mM) ; DMSO:16.67 mg/mL (64.94 mM)
Smiles
CCCCCn1c2nc (Cl) [nH]c2c (=O) [nH]c1=O
Molecular Formula
C10H13ClN4O2
Molecular Weight
256.69
Storage Conditions
-20°C
Notes
For research use only.
Available Sizes
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
